Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Canerpaturev |
Synonyms | |
Therapy Description |
Canerpaturev (HF10) is a spontaneous herpes simplex virus (HSV) type I mutant variant, which is capable of infecting and lysing tumor cells, and may also lead to non-infected tumor cell death by increasing host immune response (PMID: 31193737). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Canerpaturev | HSV-1 HF10|herpes simplex virus type 1 HF10|HF10 | Canerpaturev (HF10) is a spontaneous herpes simplex virus (HSV) type I mutant variant, which is capable of infecting and lysing tumor cells, and may also lead to non-infected tumor cell death by increasing host immune response (PMID: 31193737). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|